EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients

Clinical trial NCT01942005 · COMPLETED

Trial details

NCT number: NCT01942005
Sponsor: Andreas Arnold
Status: COMPLETED
Study type: OBSERVATIONAL

Immunosuppression Neoplasm

Start date: 2010-01-01
Primary completion: 2014-05-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.